Perturbation to the replication of the human genome, so called replication stress, is a key endogenous source of genome instability that leads to ageing, neuropathology and cancer development. DNA replication occurs in three stages: initiation, elongation and termination. Fundamental knowledge about replication initiation and elongation led to the development of replication-stress inducing drugs that target rapidly dividing cancer cells. However, despite recent breakthroughs there is still little understanding about the molecular mechanism of termination and how it can generate replication stress. This is due to the recalcitrant nature of termination to traditional experimental approaches. We seek to fill this significant gap in knowledge within the eukaryotic DNA replication field by developing novel technology and approaches to study DNA replication termination. Our multidisciplinary approach will permit direct and continuous visualization of individual eukaryotic replication forks during replication elongation and termination. Our results are anticipated to provide a significant and unique breakthrough in the replication field, spearhead new avenues of cancer therapy development, as well as providing novel assays and research tools for the international research community.
We were successful in the creation of a single-molecule imaging approach to study replication termination but ultimately further progress and dissemination of results was prevented due to the Covid-19 pandemic.